- Report
- June 2022
- 331 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- December 2023
- 197 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- July 2023
- 300 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- March 2023
- 139 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- March 2024
- 90 Pages
Middle East
From €5329EUR$5,950USD£4,543GBP
- Report
- June 2023
- 180 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- October 2023
- 156 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- January 2025
- 85 Pages
India
From €2665EUR$2,975USD£2,271GBP
€3135EUR$3,500USD£2,672GBP
- Report
- October 2023
- 172 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- September 2023
- 190 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- October 2023
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- April 2023
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- March 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- October 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- April 2023
- 150 Pages
Global
From €2911EUR$3,250USD£2,481GBP
€4344EUR$4,850USD£3,703GBP
- Report
- November 2023
- 125 Pages
Middle East, Africa
From €3090EUR$3,450USD£2,634GBP

The Embryonic Stem Cell (ESC) market is a subset of the larger stem cell market. ESCs are derived from embryos and are pluripotent, meaning they can differentiate into any cell type in the body. They are used in research to study the development of cells and tissues, and in regenerative medicine to replace damaged or diseased cells. ESCs are also used in drug discovery and development, as they can be used to test the safety and efficacy of new drugs.
The ESC market is highly regulated, as the use of embryos is controversial. Regulations vary by country, and some countries have banned the use of ESCs altogether. Despite this, the ESC market is growing, driven by advances in stem cell research and the potential for regenerative medicine.
Companies in the ESC market include Cellular Dynamics International, Pluristem Therapeutics, and Stem Cell Therapeutics. These companies are involved in the research, development, and commercialization of ESCs for therapeutic and research applications. Show Less Read more